Welcome to CDC stacks | CDC : 40 years of prevention - 21421 | David J. Sencer CDC Museum
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
CDC : 40 years of prevention
  • Published Date:
    June 1986
  • Source:
    Dateline: CDC ; v. 18, no. 5, rev.
  • Series:
    Dateline: CDC
  • Language:
    English
Filetype[PDF-7.60 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
CDC : 40 years of prevention
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Colonoscopy Screening Among US Adults Aged 40 or Older With a Family History of Colorectal Cancer
    Personal Author:
    Tsai, Meng-Han; Xirasagar, Sudha; Li, Yi-Jhen; de Groen, Piet C.;
    Published:
    May 21 2015
    Source:
    Prev Chronic Dis. 12.
    Description:
    Introduction : Colonoscopy screening reduces colorectal cancer (CRC) incidence and mortality. CRC screening is recommended at age 50 for average-risk people. Screening of first-degree relatives of CRC patients is recommended to begin at age 40 or 10 ...
    File Type:
    Filetype[PDF - 304.80 KB]
  2. Update on recommendations for use of herpes zoster vaccine
    Personal Author:
    Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.; National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.;
    Published:
    August 22, 2014
    Series:
    MMWR. Morbidity and mortality weekly report, Vol. 63, no. 33, p. 729-31
    Description:
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...
    Status:
    current
    File Type:
    Filetype[PDF - 195.85 KB]
  3. Updated ACIP recommendations for use of hepatitis A vaccine and immune globulin for post-exposure prophylaxis and for international travelers
    Personal Author:
    Link-Gelles, Ruth
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA)
    Published:
    7/13/2017
    Series:
    ACIP meeting Hepatits Vaccines
    Description:
    Presentations June 2017 Day 1 : hepatitis-05-Link-Gelles.pdf
    File Type:
    Filetype[PDF - 515.37 KB]
  4. Update on Recommendations for Use of Herpes Zoster Vaccine
    Personal Author:
    Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    Aug 22 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(33):729-731.
    Description:
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...
    File Type:
    Filetype[PDF - 109.32 KB]
  5. Percentage of Deaths Associated With Inadequate Physical Activity in the United States
    Personal Author:
    Carlson, Susan A.; Adams, E. Kathleen; Yang, Zhou; Fulton, Janet E.;
    Published:
    Mar 29 2018
    Source:
    Prev Chronic Dis. 15.
    Description:
    Introduction : Current physical activity guidelines recommend that adults participate weekly in at least 150 minutes of moderate-intensity equivalent aerobic physical activity to achieve substantial health benefits. We used a nationally representativ...
    File Type:
    Filetype[PDF - 407.25 KB]